Offstream
news

The Food and Drug Administration grants emergency use authorization for Pfizer's antiviral COVID-19 oral pill named Paxlovid for at-risk people over the age of 12 years, becoming the first at-home oral treatment to be approved by the FDA.
2021-12-22

The Food and Drug Administration authorizes the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11, becoming the first vaccine to be approved for children in the United States.
2021-10-29

The Food and Drug Administration gives full approval to the Pfizer–BioNTech COVID-19 vaccine, becoming the first vaccine in the U.S. to be granted full licensure and thereby giving businesses, schools and universities more confidence to adopt vaccine mandates.
2021-08-23

White House COVID-19 Response Coordinator Jeff Zients says that the Biden administration will accelerate doses of the Pfizer-BioNTech and Moderna vaccines. The move comes after the United States suspended usage of the Johnson & Johnson vaccine.
2021-04-14

South Africa voluntarily suspends its rollout of the Johnson & Johnson vaccine after the U.S. Food and Drug Administration recommended temporarily suspending use of the vaccine due to rare cases of blood clots.
2021-04-13

The United States suspends the use of the Johnson & Johnson vaccine following concerns of blood clots.
2021-04-13

Johnson & Johnson's single-shot COVID-19 vaccine candidate meets the standards for emergency use authorization, according to analysis from a committee within the FDA, though formal authorization will not be determined until February 26. The vaccine is 66% effective in combating the virus and can be stored in normal refrigerators.
2021-02-24

The Food and Drug Administration grants emergency use authorization for Eli Lilly and Company's combination antibody therapy bamlanivimab-etesevimab for use in COVID-19 positive adults and children aged 12 and older who are at high risk of severe disease.
2021-02-9

An expert panel advising the FDA recommends granting Tozinameran emergency approval for usage in the United States.
2020-12-10

Pfizer and BioNTech apply for an emergency use authorization from the U.S. Food and Drug Administration for their vaccine. If the application is approved, the vaccine will likely be limited and rolled out in phases.
2020-11-20